drugset / Trial / NCT00619983
Three Way Interaction Between Gabapentin, Duloxetine, and Donepezil in Patients With Diabetic Neuropathy
Phase 4
Terminated
22 enrolled
Wake Forest University
National Institute of Neurological Disorders and Stroke (NINDS) · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of the study is to determine whether the combination of the the three drugs gabapentin, duloxetine, and donepezil are effective in treating pain in people with diabetic neuropathy or patients with failed low back syndrome (chronic back pain).
Timeline
- Start
- 2008-02
- Primary completion
- 2013-05
- Completion
- 2013-05
Outcome
Outcome not reported
Stopped (Enrollment): “Study terminated due to low enrollment”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Donepezil | Small molecule | 2.5 mg | — |
| Comparator | Donepezil | Small molecule | 5 mg | — |
| Comparator | Duloxetine | Small molecule | 30 mg | — |
| Comparator | Gabapentin | Unknown | — | — |